Magnesium Choline Citrate for Cognitive Functioning

EL
Overseen ByErin Lewis, PhD
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Nutrisol, LLC

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to examine the effect of Magnesium Choline Citrate on cognitive function and anxiety in healthy adolescents and adults. The main questions it aims to answer are:

* What is the change in cognitive function, as assessed by the PROMIS Cognitive Function- Short Form 8a (≥18 years old) from baseline to Day 84 between Magnesium Choline Citrate and placebo?

* What is the change in cognitive function, as assessed by the Pediatric Cognitive Function - Short Form 7a (8 - 17 years old) from baseline to Day 84 between Magnesium Choline Citrate and placebo?

Researchers will compare Magnesium Choline Citrate with placebo to evaluate its effects on cognitive function and anxiety symptoms. Participants will be asked to:

* Consume either Magnesium Choline Citrate or placebo for 84 days

* Complete questionnaires (PROMIS Cognitive Function- Short Form 8a/Pediatric Cognitive Function - Short Form 7a, and PROMIS Emotional Distress - Anxiety - Short Form 8a/Pediatric Anxiety - Short Form 8a)

* Complete a study diary weekly

Who Is on the Research Team?

DC

David Crowley

Principal Investigator

KGK Science Inc.

Are You a Good Fit for This Trial?

This trial is for healthy adolescents (8-17 years) and adults (18+ years) who want to see if Magnesium Choline Citrate can improve thinking skills or reduce anxiety. People with serious health issues or on conflicting medications may not be eligible.

Inclusion Criteria

Generally healthy with no unstable diagnosed medical conditions
Provided voluntary, written, informed consent to participate
Agrees to maintain current lifestyle habits throughout the study
See 6 more

Exclusion Criteria

Individuals who self-report as pregnant, breastfeeding, or planning to become pregnant during the study
Any other condition or lifestyle factor that may adversely affect ability to complete study or pose significant risk
I currently have a diagnosis of stress or anxiety disorder.
See 11 more

What Are the Treatments Tested in This Trial?

Interventions

  • Magnesium Choline Citrate

Trial Overview

The study compares taking Magnesium Choline Citrate versus a placebo daily for 84 days to see if it helps with cognitive function and anxiety. Participants complete regular questionnaires and keep a weekly diary. The trial is virtual.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Magnesium Choline CitrateExperimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Nutrisol, LLC

Lead Sponsor

KGK Science Inc.

Industry Sponsor

Trials
82
Recruited
6,400+

Najla Guthrie

KGK Science Inc.

Chief Executive Officer since 1997

Research career at the Centre for Human Nutrition, University of Western Ontario

Dr. Bibiane Zakaria

KGK Science Inc.

Chief Medical Officer since 2023

MD from an unspecified institution